Botulinum Toxin Market

Botulinum Toxin Market (Product Type: Botulinum Toxin Type A and Botulinum Toxin Type B; and Application: Aesthetic and Therapeutic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Botulinum Toxin Market Outlook 2031

  • The industry was valued at US$ 6.1 Bn in 2022
  • It is estimated to grow at a CAGR of 7.5% from 2023 to 2031 and reach US$ 11.5 Bn by the end of 2031

Analyst Viewpoint

Increase in demand for cosmetic procedures and growth in R&D activities in advanced therapeutic treatments are propelling the botulinum toxin market size. Botulinum toxin is utilized in major cosmetic surgeries to reduce wrinkles and fine lines. Growth in popularity of non-invasive cosmetic surgeries among people is also fostering market progress. Technological advancements in the drug development industry enable manufacturers to revise their existing product range and enhance their product portfolio.

Leading players in the market are collaborating with healthcare organizations to increase awareness about their products and drive product sales. Moreover, stringent regulations are prompting manufacturers to focus on innovative drug development, which in turn is expected to positively influence the botulinum toxin market forecast in the next few years.

Botulinum Toxin Market

Market Introduction

Botulinum toxin or botulinum neurotoxin, called botox, is a highly potent neurotoxic protein produced by the bacterium clostridium botulinum and related species. Botulinum toxin is a medication used to manage and treat therapeutic and cosmetic purposes. Medicinal uses include chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity. Botulinum toxin injections are shots that use a toxin to prevent a muscle from moving for a limited time. These shots are often employed to smooth wrinkles on the face, treat neck spasms, reduce sweating, treat an overactive bladder, lazy eye, and other conditions.

Innovations in botulinum toxin delivery systems are ensuring safety by using natural composition to seek approval from the U.S. Food and Drug Administration. The seven main types of botulinum toxin are named types A, B, C1, C2, D, E, F, and G. Botulinum toxin type A is purified and used to block acetylcholine release in the treatment of chronic sialorrhea, muscle spasticity, and dystonia, as well as in cosmetic applications.

Botulinum toxin products are considerably more expensive, as compared to other options available in the market. Furthermore, use of botulinum toxin can cause adverse reactions, such as swelling, headache, flu-like symptoms, in some individuals. These side-effects may hamper the quality of life of the patient. Moreover, botulinum toxin products are not covered by most insurance plans or government programs, which may limit the accessibility and affordability of these products for several patients. These factors are estimated to hamper the botulinum toxin market demand in the near future.

Increase in Demand for Cosmetic Procedures Boosting Market Dynamics

Botulinum toxin is majorly used to reduce wrinkles and fine lines, as it blocks certain nerve signals that contract muscles. Growing consciousness about appearance among consumers is driving the demand for non-surgical rejuvenation. Thus, rise in demand for cosmetic procedures is fostering the botulinum toxin market value. Growth in the popularity of Botox treatments among people in the entertainment sector is driving the demand for aesthetic cosmetic procedures. Moreover, easy availability of these treatments is propelling market statistics.

According to the data published by The Aesthetic Society, surgical procedures increased by 54% and non-surgical procedures were up 44%. Body procedures increased more than any other section (+63%), led by jumps in liposuction procedures (+66%) and abdominoplasties (+49%). The average plastic surgeon performed 320 surgical procedures in 2021, as compared to 220 in 2020.

Rise in the adoption of non-invasive procedures in the cosmetics sector is fueling the botulinum toxin market development. Non-invasive cosmetic surgeries have fewer incisions, minimal pain, rapid recovery, and natural-looking results. Moreover, rise in geriatric population is driving the demand for non-invasive procedures.

Growth in R&D Activities in Advanced Therapeutic Treatments Fostering Botulinum Toxin Market Growth

Skin peels, automated pen microneedling, mesotherapy, and dermaplaning are some of the advanced therapies adopted in cosmetology. Increase in investments in research and development activities to incorporate various botulinum toxin products, such as dysport, botox, and xeomin in cosmetic surgeries is fueling the botulinum toxin industry size. Moreover, growth in the adoption of advanced treatments for chemical browlift, glabellar lines, and forehead lines is driving the demand for botulinum toxin.

Rise in skin concerns, including early aging, skin peeling, acne, and dry skin due to pollution and changing dietary habits is propelling the botulinum toxin industry growth. Pollution and lack of nutritious diet can cause skin issues, leading to early signs of aging.

Regional Outlook

As per the latest botulinum toxin market insights, North America dominated the global market in 2022. Increase in awareness about non-surgical aesthetic and therapeutic procedures and easy availability of treatments is likely to propel the botulinum toxin industry share in the next few years. Rise in product launches by companies and growth in regulatory approvals for drugs are driving market expansion.

For instance, according to the International Society of Aesthetic Plastic Surgery, approximately 2,520,000 botulinum toxin procedures were performed in the U.S. in 2021. Increase in adoption of advanced therapies in cosmetology is driving the demand for botulinum toxin.

Analysis of Key Players in Botulinum Toxin Industry

Leading companies in the botulinum toxin industry are launching new products with advanced technologies and seeking regulatory approvals to improve their product portfolio. They are investing in R&D to analyze current trends in the market in order to develop products accordingly. Manufacturers of botulinum toxin are entering into partnerships with healthcare organizations to promote their products and boost revenues.

Some of the leading companies in the industry are AbbVie, Inc., Ipsen Pharma, Medytox, Merz Pharma, US Worldmeds, LLC, Nestle Skin Health, Metabiologics, Inc., Hugel, Inc., Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics, Inc.

Key players in the botulinum toxin market report have been profiled based on various parameters such as company overview, financial overview, business segments, product portfolio, business strategies, and key developments.

Key Developments

  • In October 2022, Hugel America, Inc., a global leader in the medical aesthetics industry, announced the acceptance of its Biologics License Application for letibotulinumtoxinA, by the U.S. Food and Drug Administration (FDA). The FDA considered resubmission a Class 2 response and assigned an April 6, 2023 action date as per the Prescription Drug User Fee Act (PDUFA).
  • In July 2022, Fastox Pharma, a developer of drugs boosting botulinum toxin performance technology intended for aesthetic and therapeutic applications, launched long-lasting botulinum toxin LAST technology at the 'Toxins 2022 International Conference'. Fastox discovered that combining botulinum toxin type A (BoNT/A) with fast-acting myorelaxant drugs is anticipated to accelerate the BoNT/A onset of action.

Botulinum Toxin Market Overview

Attribute Detail
Market Size in 2022 US$ 6.1 Bn
Market Forecast (Value) in 2031 US$ 11.5 Bn
Growth Rate (CAGR) 7.5%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product Type
    • Botulinum Toxin Type A
    • Botulinum Toxin Type B
  • Application
    • Aesthetic
    • Therapeutic
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Brazil
  • Mexico
  • South Africa
  • GCC countries
Companies Profiled
  • AbbVie, Inc.
  • Ipsen Pharma
  • Medytox
  • Merz Pharma
  • US Worldmeds, LLC
  • Nestle Skin Health
  • Metabiologics, Inc.
  • Hugel, Inc.
  • Lanzhou Institute of Biological Products Co. Ltd.
  • Revance Therapeutics, Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global botulinum toxin market in 2022?

The global market was valued at US$ 6.1 Bn in 2022

How is the botulinum toxin industry expected to grow by 2031?

It is projected to expand at a CAGR of 7.5% from 2023 to 2031

What are the key factors driving the demand for botulinum toxin?

Increase in demand for cosmetic procedures and growth in R&D activities in advanced therapeutic treatments

Which was the most lucrative region for the botulinum toxin business in 2022?

North America was the most lucrative region in 2022

Who are the prominent botulinum toxin manufacturers?

AbbVie, Inc., Ipsen Pharma, Medytox, Merz Pharma, US Worldmeds, LLC, Nestle Skin Health, Metabiologics, Inc., Hugel, Inc., Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics, Inc.

    1. Executive Summary

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Botulinum Toxin Market

    4. Market Overview

        4.1. Market Segmentation

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Botulinum Toxin Market Analysis and Forecasts, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. COVID-19 Pandemic Impact on Industry

    6. Botulinum Toxin Market Analysis and Forecast, by Product Type

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Botulinum Toxin Type A

            6.3.2. Botulinum Toxin Type B

        6.4. Market Attractiveness, by Product Type

    7. Global Botulinum Toxin Market Analysis and Forecast, by Application

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Aesthetic

            7.3.2. Therapeutic

        7.4. Market Attractiveness, by Application

    8. Global Botulinum Toxin Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region, 2017–2031

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness, by Region

    9. North America Botulinum Toxin Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Product Type, 2017–2031

            9.2.1. Botulinum Toxin Type A

            9.2.2. Botulinum Toxin Type B

        9.3. Market Value Forecast, by Application, 2017–2031

            9.3.1. Aesthetic

            9.3.2. Therapeutic

        9.4. Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product Type

            9.5.2. By Application

            9.5.3. By Country

    10. Europe Botulinum Toxin Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2031

            10.2.1. Botulinum Toxin Type A

            10.2.2. Botulinum Toxin Type B

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Aesthetic

            10.3.2. Therapeutic

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product Type

            10.5.2. By Application

            10.5.3. By Country/Sub-region

    11. Asia Pacific Botulinum Toxin Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Botulinum Toxin Type A

            11.2.2. Botulinum Toxin Type B

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Aesthetic

            11.3.2. Therapeutic

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product Type

            11.5.2. By Application

            11.5.3. By Country/Sub-region

    12. Latin America Botulinum Toxin Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Botulinum Toxin Type A

            12.2.2. Botulinum Toxin Type B

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Aesthetic

            12.3.2. Therapeutic

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product Type

            12.5.2. By Application

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Botulinum Toxin Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Botulinum Toxin Type A

            13.2.2. Botulinum Toxin Type B

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Aesthetic

            13.3.2. Therapeutic

        13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Product Type

            13.5.2. By Application

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2022)

        14.3. Company Profiles

            14.3.1. AbbVie, Inc.

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. Financial Overview

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. Ipsen Pharma

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. Financial Overview

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

            14.3.3. Medytox

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Product Portfolio

                14.3.3.3. Financial Overview

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Merz Pharma

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. Financial Overview

                14.3.4.4. SWOT Analysis

                14.3.4.5. Strategic Overview

            14.3.5. US Worldmeds, LLC

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Product Portfolio

                14.3.5.3. Financial Overview

                14.3.5.4. SWOT Analysis

                14.3.5.5. Strategic Overview

            14.3.6. Nestle Skin Health

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Product Portfolio

                14.3.6.3. Financial Overview

                14.3.6.4. SWOT Analysis

                14.3.6.5. Strategic Overview

            14.3.7. Metabiologics, Inc.

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Product Portfolio

                14.3.7.3. Financial Overview

                14.3.7.4. SWOT Analysis

                14.3.7.5. Strategic Overview

            14.3.8. Hugel, Inc.

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Product Portfolio

                14.3.8.3. Financial Overview

                14.3.8.4. SWOT Analysis

                14.3.8.5. Strategic Overview

            14.3.9. Lanzhou Institute of Biological Products Co. Ltd.

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Product Portfolio

                14.3.9.3. Financial Overview

                14.3.9.4. SWOT Analysis

                14.3.9.5. Strategic Overview

            14.3.10. Revance Therapeutic, Inc.

                14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.10.2. Product Portfolio

                14.3.10.3. Financial Overview

                14.3.10.4. SWOT Analysis

                14.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 02: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 04: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 06: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 09: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 11: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 14: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 17: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 18: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Botulinum Toxin Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Botulinum Toxin Market Value Share Analysis, by Application 2022 and 2031

    Figure 03: Global Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 04: Global Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 05: Global Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 06: Global Botulinum Toxin Market Value Share Analysis, by Region, 2022 and 2031

    Figure 07: Global Botulinum Toxin Market Attractiveness Analysis, by Region, 2023–2031

    Figure 08: North America Botulinum Toxin Market Value (US$ Mn) Forecast, 2017–2031

    Figure 09: North America Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 10: North America Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 11: North America Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 12: North America Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 13: North America Botulinum Toxin Market Value Share Analysis, by Country, 2022 and 2031

    Figure 14: North America Botulinum Toxin Market Attractiveness Analysis, by Country, 2023–2031

    Figure 15: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, 2017–2031

    Figure 16: Europe Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 17: Europe Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 18: Europe Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 19: Europe Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 20: Europe Botulinum Toxin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 21: Europe Botulinum Toxin Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 22: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, 2017–2031

    Figure 23: Asia Pacific Botulinum Toxin Market Value Share Analysis, by Application 2022 and 2031

    Figure 24: Asia Pacific Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 25: Asia Pacific Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 26: Asia Pacific Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 27: Asia Pacific Botulinum Toxin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 28: Asia Pacific Botulinum Toxin Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, 2017–2031

    Figure 30: Latin America Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 31: Latin America Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 32: Latin America Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 33: Latin America Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 34: Latin America Botulinum Toxin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 35: Latin America Botulinum Toxin Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 36: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, 2017–2031

    Figure 37: Middle East & Africa Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 38: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 39: Middle East & Africa Botulinum Toxin Market Value Share Analysis, by Application, 2022 and 2031

    Figure 40: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, by Application, 2023–2031

    Figure 41: Middle East & Africa Botulinum Toxin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 42: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 43: Global Botulinum Toxin Market Share Analysis, by Company, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved